All Articles: News
Ahmar U. Zaidi, MD, Medical Director, Clinical Development, Sickle Cell Disease Program at Agios Pharmaceuticals presented "The Sickle Caste: From a Single Mutation to Victimization and the Road Back".
New role becomes effective July 18, 2022.
Hussain will start Aug. 1 and brings tremendous knowledge and experience.
In this role, Palombi will provide vision, oversight and management of the professional program.
Shultz joins the college with tremendous experience, both at the University of Minnesota and in higher education.
The results of Phase 2 clinical trials for glaucoma drug QLS-101 have demonstrated a favorable safety and tolerability profile, according to a news release by Qlaris Bio, which licensed the drug in 2019. A positive efficacy signal was also reported.
The Midwest Antiviral Drug Discovery (AViDD) Center is part of a network of nine national centers established in response to the public health emergency.
Dr. Olihe Okoro is 2022 recipient of the University of Minnesota President's Community-Engaged Scholar Award
Goal of new center is to transform the way pharmaceutical drugs are formulated and manufactured.
Dr. Vicki Ellingrod has been named dean of the University of Michigan College of Pharmacy, effective July 1, 2022. Ellingrod is an alumna of the University of Minnesota College of Pharmacy where she received her bachelor’s degree in pharmacy in 1992 and her Doctor of Pharmacy in 1994.